- Ut imperdiet leo id lorem fermentum consectetur.
- Ut vitae orci et dui varius tincidunt.
- Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Best Practice
The emerging movement of purpose-driven organisations

Based on the concepts of purpose, life-purpose and organisational purpose, Debbie Haski-Leventhal’s TEDx video shares the emerging movement of purpose-driven organisations, in which leadership and staff work together to shift from being best in the world to being best for the world through community engagement and impact.
Debbie Haski-Leventhal is a Professor of Management at Macquarie Business School, an expert of corporate social responsibility (CSR) and volunteerism. Together with the United Nations PRME, she conducts studies on responsible management education. She has published over 100 papers and her work was covered many times by the media, including the New York Times.
She is the author of ‘Strategic CSR’ and the upcoming book, ‘The purpose-driven university’.
You may also like 91% of clinicians use reprints to improve patient care
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
News & Trends - Medical Technology

Technology levels up support for healthcare employees – Matt Moran, MD, Philips
MedTech News: Matt Moran, Managing Director of Philips Australia & New Zealad, reflects on the impact of the COVID-19 pandemic […]
MoreMedical

Aussie researchers receive $2.9m funding boost for multiple sclerosis
Medical News: Twenty multiple sclerosis (MS) scientific research teams across the country will receive an important New Year funding injection […]
MoreNews & Trends - Biotechnology

AusBiotech renews agreements with international stakeholders
Biotech News: AusBiotech’s international partnerships have been extended, with new Memorandums of Understanding (MoU) signed with major international industry associations […]
MoreNews & Trends - Pharmaceuticals

AbbVie’s phase 3 wins for Humira successor Skyrizi
Pharma News: AbbVie is in a race against time as patent expiry of its Humira inflammatory diseases blockbuster draws near […]
More